Opportunity exists to enhance supportive care using pharmacogenomics in gastrointestinal cancer, indicating medicine accessibility challenges.
There is an opportunity to improve supportive care in gastrointestinal cancer patients through pharmacogenomics though some specific medicines challenges to full implementations are due to limited registered medicines.
No takes yet. Share an insight, caveat, or question.
Mazhindu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: